logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Josh J. Carlson

University of Washington

30H指数
179论文数
3.2K被引数
收录论文 64
发表时间
logo
Evaluating Long-term Health Disparity Impacts of Clinical Algorithms Using a Patient-level Simulation Framework评估临床算法对长期健康差异影响的基于患者层面的模拟框架
errValue in Health
IF6
err2025-10-15
err0
PREAI
errSara Khor; Anirban Basu; Veena Shankaran; Kyueun Lee; Eric C. Haupt; Erin E. Hahn; Josh J. Carlson; Aasthaa Bansal
err分享
err收藏
The association between new cancer therapy innovations and financial toxicity新癌症疗法创新与经济毒性的关联
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2025-07-01
err1
PREAI
errKhor, Sara; Carlson, Josh J.; Basu, Anirban; Bansal, Aasthaa; Yu, Kaiyue; Fedorenko, Catherine R.; Ramsey, Scott; Shankaran, Veena
err分享
err收藏
Author Reply作者回复
errValue in Health
IF6
err2025-07-01
err0
PREAI
errYilin Chen; Peter Martin; Lurdes Y.T. Inoue; Anirban Basu; Josh J. Carlson
err分享
err收藏
Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and polygenic risk scores to inform colorectal cancer screening林奇综合征和polygenic risk scores的群体性基因组筛查在结直肠癌筛查中的成本效益分析
errGENETICS IN MEDICINE
IF6.2
err2025-02-01
err0
PREAI
errJiang, Shangqing; Guzauskas, Gregory F.; Garbett, Shawn; Graves, John A.; Williams, Marc S.; Hao, Jing; Zhu, Jinyi; Jarvik, Gail P.; Carlson, Josh J.; Peterson, Josh F.
err分享
err收藏
MRD Testing in Multiple Myeloma: Modeling the Potential Clinical and Economic Outcomes Based on the Master TrialMRD检测在多发性骨髓瘤中的应用：基于主试验模型分析其潜在的临床和经济结果
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errElsea, David; Carlson, Josh J.; Eckert, Benjamin; Hewitt, Anthony; Costa, Luciano J.
err分享
err收藏
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study
errVALUE IN HEALTH
IF6
err2024-07-01
err0
PREAI
errChen, Yilin; Martin, Peter; Inoue, Lurdes Y. T.; Basu, Anirban; Carlson, Josh J.
err分享
err收藏
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework评估扩大与限制一线治疗选择的政策: 成本效益分析框架
errVALUE IN HEALTH
IF6
err2024-04-01
err3
PREAI
errJiao, Boshen; Carlson, Josh J.; Garrison, Louis P., Jr.; Basu, Anirban
err分享
err收藏
Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
errVALUE IN HEALTH
IF6
err2024-02-01
err9
errOAAI
errCarlson, Josh; Foos, Volker; Kasle, Adam; Mugwagwa, Tendai; Draica, Florin; Wiemken, Timothy Lee; Nguyen, Jennifer L.; Cha-Silva, Ashley; Migliaccio-Walle, Kristen; Dzingina, Mendy
err分享
err收藏
Quantifying the value of older adult-specific clinical trials: Post-lumpectomy irradiation among older adults with early-stage breast cancer
errJOURNAL OF GERIATRIC ONCOLOGY
IF2.7
err2023-05-01
err0
PREAI
errLee, Woojung; Carlson, Josh J.; Basu, Anirban; Veenstra, David
err分享
err收藏
How Much Does the US Public Value Equity in Health? A Systematic Review
errVALUE IN HEALTH
IF6
err2023-03-01
err3
errOAAI
errKhor, Sara; Elsisi, Zizi A.; Carlson, Josh J.
err分享
err收藏
Can we predict trial failure among older adult-specific clinical trials using trial-level factors?我们能否使用试验水平因素来预测老年人特定临床试验的试验失败？
errJOURNAL OF GERIATRIC ONCOLOGY
IF2.7
err2023-01-01
err0
PREAI
errLee, Woojung; Basu, Anirban; Carlson, Josh J.; Veenstra, David
err分享
err收藏
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2022-10-01
err1
errOAAI
errJiao, Boshen; Nyame, Yaw A.; Carlson, Josh J.; Garrison, Louis P., Jr.; Basu, Anirban
err分享
err收藏
Assessing Payers' Preferences for Real-World Evidence in the United States: A Discrete Choice Experiment
errVALUE IN HEALTH
IF6
err2022-03-01
err4
PREAI
errSaldarriaga, Enrique M.; Hauber, Brett; Carlson, Josh J.; Barthold, Douglas; Veenstra, David L.; Devine, Beth
err分享
err收藏
The budget impact of the DiviTum®TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer
errCANCER RESEARCH
IF16.6
err2022-02-15
err0
PREAI
errGuzauskas, Gregory F.; Carlson, Josh J.; Dann, Robert A.; Ramsey, Scott D.
err分享
err收藏
Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation
errVALUE IN HEALTH
IF6
err2020-12-01
err17
errOAAI
errCarlson, Josh J.; Brouwer, Elizabeth D.; Kim, Eunice; Wright, Phoebe; McQueen, R. Brett
err分享
err收藏
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model
errMEDICAL DECISION MAKING
IF2.3
err2020-11-11
err9
errOAAI
errKremer, Ingrid E. H.; Hiligsmann, Mickael; Carlson, Josh; Zimmermann, Marita; Jongen, Peter J.; Evers, Silvia M. A. A.; Petersohn, Svenja; Pouwels, Xavier G. L. V.; Bansback, Nick
err分享
err收藏
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States
errCANCER
IF5.1
err2020-01-30
err27
errOAAI
errLi, Ang; Carlson, Josh J.; Kuderer, Nicole M.; Schaefer, Jordan K.; Li, Shan; Garcia, David A.; Khorana, Alok A.; Carrier, Marc; Lyman, Gary H.
err分享
err收藏
Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis
errVALUE IN HEALTH
IF6
err2020-01-01
err44
errOAAI
errBasu, Anirban; Carlson, Josh; Veenstra, David
err分享
err收藏
The Potential Long-Term Comparative Effectiveness of Larotrectinib vs. Entrectinib for Second-Line Treatment of NTRK Fusion-Positive Metastatic Non-Small Cell Lung Cancer
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2019-12-01
err1
PREAI
errRoth, Joshua A.; Carlson, Josh J.; Williamson, Todd; Sullivan, Sean D.
err分享
err收藏
Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy
errVALUE IN HEALTH
IF6
err2019-09-01
err3
errOAAI
errGuzauskas, Gregory F.; Basu, Anirban; Carlson, Josh J.; Veenstra, David L.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gary H. Lyman
H 指数: 128 · 论文数: 948
K
Kris V. Kowdley
H 指数: 118 · 论文数: 1.0K
J
Julie R. Gralow
H 指数: 87 · 论文数: 472
R
Roger R. Dmochowski
H 指数: 85 · 论文数: 1.0K
P
Peter J. Neumann
H 指数: 84 · 论文数: 513
查看更多